PharmaShots | Incisive News in 3 Shots

Subscribe Now

Pfizer’s Litfulo

Pfizer’s Litfulo (ritlecitinib) Receives the US FDA’s Approval for Adults and Adolescents with Severe Alopecia Areata

Pfizer’s Litfulo (ritlecitinib) Receives the US FDA’s Approval for Adults and Adolescents with Severe Alopecia Areata

June 26, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us